①Licensing
日本語
/
English
日本語
/
English
NEWS
COMPANY
Message
Company Philosophy
Company Information
Introduction of Board of Directors
BUSINESS
Business Model
HDO Trial Service
TECHNOLOGY
Structure, Mechanism of Action, KD Action
Reduction of Toxicity
Ligands for DDS
Newly modified nucleic acids
CONTACT US
HOME
BUSINESS
①Licensing
①Licensing
Rena licenses HDO technology to pharmaceutical companies.